SUPPORTS HEALTHY APPETITE CONTROL
(Chromium Picolinate + Gymnema extract)
SUPPORTS GLYCOLYTIC & GLUCOSE PATHWAYS
(Chromium + Gymnema + Biotin)
ENHANCES SUSTAINED ENERGY METABOLISM
(Chromium + Biotin)
SUPPORTS METABOLIC BALANCE ASSOCIATED WITH HEALTHY WEIGHT MANAGEMENT
Metabolic homeostasis and appetite regulation depend on nutrient-sensing pathways, glycemic modulation, chromium-dependent enzymatic activity, and insulin signaling efficiency—physiological domains influenced in contexts of appetite dysregulation and metabolic stress.
N1 Skinny Blend is a clinician-developed oral dissolvable film formulation designed for daily use to reinforce these convergent biological systems using clinically studied cofactors and botanical substrates.
This formulation integrates chromium cofactors, gymnema leaf extract, insulin-modulating micronutrients, and film-based delivery to support appetite regulation and metabolic efficiency identified in human clinical research.
Chromium Picolinate (0.10 mg per film)
Chromium has been evaluated in controlled human trials demonstrating improved insulin signaling, glucose metabolism, and glycemic modulation—areas directly relevant to appetite control and energy utilization.
Gymnema Leaf Extract
Gymnema sylvestre has been investigated in human trials for its effects on glycemic response and sweet taste modulation, with implications for appetite regulation.
Biotin
Biotin supports multiple metabolic enzyme systems involved in carbohydrate, fat, and energy metabolism. Controlled research has shown biotin’s role in metabolic regulation.
Serving Size: 1 film
Servings Per Box: 10
Allow film to dissolve sublingually for rapid absorption.
Designed for consistent daily use as part of a comprehensive metabolic support strategy.
The nutrient components within this formulation have been evaluated in controlled human trials examining glycemic modulation, appetite signaling pathways, and metabolic enzyme activity.
Assessed in randomized controlled trials demonstrating improved glucose tolerance
and insulin signaling markers in adults.
Anderson et al., Diabetes (1997)
https://pubmed.ncbi.nlm.nih.gov/9353607/
Evaluated in controlled human trials examining glycemic response and sweet taste
modulation, supporting appetite and metabolic endpoints.
Shanmugasundaram et al., Journal of Ethnopharmacology (1990)
https://pubmed.ncbi.nlm.nih.gov/2255507/
Studied in human trials for its role in supporting metabolic enzyme systems involved in
carbohydrate and lipid metabolism.
Zempleni et al., Journal of Nutrition (2001)
https://pubmed.ncbi.nlm.nih.gov/11238785/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Ask Ned
Beta
